EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis

Priyanka Hayre

Cureus · 12.11.2026

DOI: 10.7759/cureus.119544 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cureus, erschienen am 12.11.2026. Verfasst von Priyanka Hayre. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hayre, P. (2026). The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.119544

Vancouver

Hayre P. The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis. Cureus. 2026. doi:10.7759/cureus.119544

BibTeX
@article{Hayre2026,
  author = {Hayre, Priyanka},
  title = {The Role of Biologic Therapies (Belimumab and Anifrolumab) in Systemic Lupus Erythematosus (SLE) Disease Activity and Renal Outcomes in Predominantly Young Female Trial Populations: A Systematic Review and Meta-Analysis},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119544}
}
Kostenlos starten →